<DOC>
	<DOCNO>NCT01400308</DOCNO>
	<brief_summary>Multicenter Clinical Trial , experimental , randomized prospective study determine effectiveness two protocol address Corporal Decolonization patient colonize Methicillin Resistant Staphylococcus Aureus ( MRSA ) . PRIMARY END POINT The aim trial evaluate effectiveness protocol Prontoderm® decolonization MRSA patient , compare protocol `` Consensus Document GEIH-SEIMC SEMPSPH '' ( see attach extract document , Annex 7 ) . Prontoderm ® Class III Medical Device CE mark own B.BRAUN Medical SA , currently available Spain indication propose trial .</brief_summary>
	<brief_title>Effectiveness Two Protocols Corporal Decolonization Patients Colonized Methicillin Resistant Staphylococcus Aureus ( MRSA )</brief_title>
	<detailed_description>Design : Multicenter , experimental , randomized prospective study . The patient consecutively alternately assigned comparison group . Randomization assure central randomization first patient one group , , centrally , back two group . Group A treat protocol describe `` Consensus document GEIH-SEIMC SEMPSPH '' Version 31/10/07 , show list Table 4 . It protocol 5 day ( nasal mupirocin chlorhexidine , potentially plus systemic antibiotic 7 day ) . Group B treat protocol establish Prontoderm® five day eventually plus systemic antibiotic . Ensure correct application treatment without interruption weekend indicate protocol . Sample Calculation : The investigator propose initial sample 310 patient bilateral approach type I error α = 0.05 β type II error 20 % . Analysis : Simple analysis logistic regression ( adjust risk factor , source , concomitant therapy , etc ) compare frequency decolonization MRSA , accord source . Procedures : To collect information use standardized form CRD paper hospital , indicate parameter list protocol culture do baseline monitoring culture DISEASE IN STUDY This treat either follow condition : MRSA Colonization : The presence organism flora patient , detect positive culture MRSA , diagnosis infection . MRSA infection : presence organism flora patient , detect positive culture MRSA , presence MRSA infection diagnose accord criterion EPINE 2009 ( Annex 8 ) .</detailed_description>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<mesh_term>Mupirocin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<criteria>MRSA infect colonized Patients Patients whose condition treatment interfere proper implementation propose protocol , : Patients admit ICU Patients undergoing resuscitation Immobilized patientsavoiding complete hygiene Patients carry nasogastric tube Patients tracheostomy / assist mechanical ventilation Patients unable , neither representative , give valid inform consent . Patients whose discharged plan complete protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Methicillin Resistant Staphylococcus Aureus colonization .</keyword>
	<keyword>Methicillin Resistant Staphylococcus Aureus infection .</keyword>
</DOC>